H. Rabes

Kisten ras mutations in patients with colorectal cancer: the “RASCAL II” study.

David Cunningham, J. Oates, Joanne Young et al. · IRIS UNIMORE (University of Modena and Reggio Emilia) · 2001 · 886 citations · Full text

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

Raffaele Ciampi, Jeffrey A. Knauf, Roswitha Kerler et al. · Journal of Clinical Investigation · 2005 · 436 citations · Full text

Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.

H. Rabes, Evgenij P. Demidchik, Juri D. Sidorow et al. · PubMed · 2000 · 370 citations

Clinical Implications, Radiation-induced Ret, Gene Rearrangements +12

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

Jervoise Andreyev, A. R. Norman, David Cunningham et al. · British Journal of Cancer · 2001 · 204 citations · Full text

The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas

Sabine Klugbauer, H. Rabes · Oncogene · 1999 · 170 citations

Signal Transduction, Receptor Tyrosine Kinase, Thyroid Disease +10